OTC dandruff monograph
This article was originally published in The Tan Sheet
Executive Summary
The final monograph for OTC dandruff, seborrheic dermatitis and psoriasis drug products is being amended to include the combination of 1.8% coal tar solution and 1.5% menthol in a shampoo drug product to control dandruff, FDA says in a March 6 Federal Register notice. The regulation is effective April 5, 2007. The agency solicited comments on the proposed amendment in late 2005, but did not receive any responses (1"The Tan Sheet" Dec. 12, 2005, p. 6)...
You may also be interested in...
FDA Proposes Coal Tar/Menthol Addition To OTC Dandruff Monograph
The final monograph for OTC dandruff, seborrheic dermatitis and psoriasis drug products would be amended to include a specific combination of coal tar and menthol under a proposed rule published by FDA in the Federal Register Dec. 9
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.